As of 2025-07-06, the Intrinsic Value of CellaVision AB (CEVI.ST) is 182.58 SEK. This CEVI.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 184.00 SEK, the upside of CellaVision AB is -0.80%.
The range of the Intrinsic Value is 116.32 - 509.95 SEK
Based on its market price of 184.00 SEK and our intrinsic valuation, CellaVision AB (CEVI.ST) is overvalued by 0.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 116.32 - 509.95 | 182.58 | -0.8% |
| DCF (Growth 10y) | 137.77 - 574.25 | 211.77 | 15.1% |
| DCF (EBITDA 5y) | 119.26 - 240.79 | 171.44 | -6.8% |
| DCF (EBITDA 10y) | 137.23 - 276.71 | 194.85 | 5.9% |
| Fair Value | 54.63 - 54.63 | 54.63 | -70.31% |
| P/E | 158.15 - 217.50 | 195.68 | 6.3% |
| EV/EBITDA | 82.11 - 168.35 | 136.84 | -25.6% |
| EPV | 74.98 - 107.76 | 91.37 | -50.3% |
| DDM - Stable | 79.49 - 502.75 | 291.12 | 58.2% |
| DDM - Multi | 105.42 - 503.77 | 172.79 | -6.1% |
| Market Cap (mil) | 4,388.40 |
| Beta | 0.64 |
| Outstanding shares (mil) | 23.85 |
| Enterprise Value (mil) | 4,229.04 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.38% |
| Cost of Debt | 4.25% |
| WACC | 6.36% |